Evonik Rejects BASF’s €10.3 Billion Takeover Bid

A rejected approach between two German chemicals majors is a consolidation signal, not a deal: the bid's existence confirms that large specialty-chemical players see strategic value in scale right now, even as the target's board disagrees on price. For RWA and crypto markets this matters indirectly, since chemical producers are increasingly tokenized and financed through on-chain instruments, and any eventual combination would reshape the issuer base behind such assets. Whether BASF returns with a revised offer, or Evonik's rejection proves final, is the open question.